4.6 Article

Does CHA2DS2-VASc Improve Stroke Risk Stratification in Postmenopausal Women with Atrial Fibrillation?

Journal

AMERICAN JOURNAL OF MEDICINE
Volume 126, Issue 12, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2013.05.023

Keywords

Atrial fibrillation; CHADS(2); CHA(2)DS(2)-VASc; Stroke; Women

Funding

  1. Women's Health Initiative (WHI) Program Office: (National Heart, Lung, and Blood Institute, Bethesda, MD)
  2. WHI Investigators and Academic Centers: (Brigham and Women's Hospital, Harvard Medical School, Boston, MA)
  3. WHI Clinical Coordinating Center (Fred Hutchinson Cancer Research Center, Seattle, WA)
  4. MedStar Health Research Institute/Georgetown-Howard Center for Clinical and Translational Sciences
  5. Stanford Prevention Research Center, Stanford, CA
  6. Ohio State University, Columbus, OH
  7. University of Arizona, Tucson/Phoenix, AZ
  8. University at Buffalo, Buffalo, NY
  9. University of Florida, Gainesville/Jacksonville, FL
  10. University of Iowa, Iowa City/Davenport, IA
  11. University of Pittsburgh, Pittsburgh, PA
  12. Wake Forest University School of Medicine, Winston-Salem, NC

Ask authors/readers for more resources

BACKGROUND: Risk stratification of atrial fibrillation patients with a congestive heart failure (C), hypertension (H), age >= 75 (A), diabetes (D), stroke or transient ischemic attack (TIA) (S-2) (CHADS(2)) score of <2 remains imprecise, particularly in women. Our objectives were to validate the CHADS(2) and congestive heart failure (C), hypertension (H), age >= 75 (A(2)), diabetes (D), stroke, TIA or prior thromboembolic disease (S-2)- vascular disease (V), age 65-74 (A), female gender (S) (CHA(2)DS(2)-VASc) stroke risk scores in a healthy cohort of American women with atrial fibrillation and to determine whether CHA(2)DS(2)-VASc further risk-stratifies individuals with a CHADS(2) score of <2. METHODS: We identified a cohort of 5981 women with atrial fibrillation not on warfarin at baseline (mean age 65.9 +/- 7.2 years) enrolled in the Women's Health Initiative and followed for a median of 11.8 years. Univariate and multivariate proportional hazards analyses were used to examine these 2 risk scores, with main outcome measures being annualized event rates of ischemic stroke or transient ischemic attack stratified by risk score. RESULTS: Annualized stroke/transient ischemic attack rates ranged from 0.36% to 2.43% with increasing CHADS(2) score (0-4+) (hazard ratio [HR] 1.57; 95% confidence interval [CI], 1.45-1.71 for each 1-point increase) and 0.20%-2.02% with increasing CHA(2)DS(2)-VASc score (1-6+) (HR 1.50; 95% CI, 1.41-1.60 for each 1-point increase). CHA(2)DS(2)-VASc had a higher c statistic than CHADS(2): 0.67 (95% CI, 0.65-0.69) versus 0.65 (95% CI, 0.62-0.67), P <.01. For CHADS(2) scores <2, stroke risk almost doubled with every additional CHA(2)DS(2)-VASc point. CONCLUSIONS: Although both CHADS(2), and CHA(2)DS(2)-VASc are predictive of stroke risk in postmenopausal women with atrial fibrillation, CHA(2)DS(2)-VASc further risk-stratifies patients with a CHADS(2) score <2. (C) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available